Guanylate cyclase-C agonist
A peptide that acts in the gut, used for constipation-predominant IBS and chronic constipation.
Supported by clinical trials for its approved gastrointestinal indications.
Prescriber-managed; the most common side effect is diarrhoea.
A registered prescription medicine for defined gastrointestinal indications.
Prescription-only for an approved indication.
This entry is general information about Linaclotide, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.
This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.